TG Therapeutics, Inc. (TGTX)
NASDAQ · Healthcare
TG Therapeutics, Inc. Shareholder Equity 2016–2025
TG Therapeutics, Inc. annual shareholder equity history from 2016 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- TG Therapeutics, Inc. shareholder equity as of December 31, 2025: 648.0M, a 191.42% increase year-over-year.
- TG Therapeutics, Inc. shareholder equity for 2025 were 648.0M, a 191.42% increase from 2024.
- TG Therapeutics, Inc. shareholder equity for 2024 were 222.4M, a 38.54% increase from 2023.
- TG Therapeutics, Inc. shareholder equity for 2023 were 160.5M, a 173.95% increase from 2022.
- TG Therapeutics, Inc. shareholder equity for 2022 were 58.6M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| TG Therapeutics, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $648 |
| 2024 | $222 |
| 2023 | $161 |
| 2022 | $59 |
| 2021 | $237 |
| 2020 | $519 |
| 2019 | $39 |
| 2018 | $24 |
| 2017 | $67 |
| 2016 | $36 |
TG Therapeutics, Inc. Shareholder Equity — FAQ
TG Therapeutics, Inc. (TGTX) shareholder equity over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TGTX's shareholder equity history?
The chart and table above show TG Therapeutics, Inc.'s shareholder equity by year and by quarter, including the growth rate.